PT2733205T - Neurónios motores superiores corticoespinhais, métodos e composições para diferenciar células estaminais neuronais por modulação da sinalização do recetor canabinoide cb1 e seus usos - Google Patents

Neurónios motores superiores corticoespinhais, métodos e composições para diferenciar células estaminais neuronais por modulação da sinalização do recetor canabinoide cb1 e seus usos

Info

Publication number
PT2733205T
PT2733205T PT123824559T PT12382455T PT2733205T PT 2733205 T PT2733205 T PT 2733205T PT 123824559 T PT123824559 T PT 123824559T PT 12382455 T PT12382455 T PT 12382455T PT 2733205 T PT2733205 T PT 2733205T
Authority
PT
Portugal
Prior art keywords
stellic
corticoespinhaes
canabinoide
neurones
modulating
Prior art date
Application number
PT123824559T
Other languages
English (en)
Portuguese (pt)
Inventor
Galve-Roperh Ismael
Guzmán Pastor Manuel
Díaz-Alonso Javier
Aguado Sanchez Tania
Paraí­So Luna Juan
Original Assignee
Univ Madrid Complutense
Centro De Investig Biomedica En Red De Enfermedades Neurodegenerativas Ciberned
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Madrid Complutense, Centro De Investig Biomedica En Red De Enfermedades Neurodegenerativas Ciberned filed Critical Univ Madrid Complutense
Publication of PT2733205T publication Critical patent/PT2733205T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • C12N5/0619Neurons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/658Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/80Neurotransmitters; Neurohormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PT123824559T 2012-11-20 2012-11-20 Neurónios motores superiores corticoespinhais, métodos e composições para diferenciar células estaminais neuronais por modulação da sinalização do recetor canabinoide cb1 e seus usos PT2733205T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12382455.9A EP2733205B1 (en) 2012-11-20 2012-11-20 Corticospinal upper motor neurons, methods and compositions for differentiating neural stem cells by modulating CB1 cannabinoid receptor signaling and uses thereof

Publications (1)

Publication Number Publication Date
PT2733205T true PT2733205T (pt) 2018-05-09

Family

ID=47221998

Family Applications (1)

Application Number Title Priority Date Filing Date
PT123824559T PT2733205T (pt) 2012-11-20 2012-11-20 Neurónios motores superiores corticoespinhais, métodos e composições para diferenciar células estaminais neuronais por modulação da sinalização do recetor canabinoide cb1 e seus usos

Country Status (6)

Country Link
EP (2) EP2733205B1 (enExample)
DK (1) DK2733205T3 (enExample)
ES (1) ES2670590T3 (enExample)
HR (1) HRP20180566T1 (enExample)
NO (1) NO2733205T3 (enExample)
PT (1) PT2733205T (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017081033A1 (en) * 2015-11-09 2017-05-18 Universite De Nice Sophia Antipolis Cell differentiation or reprogramming using fezf2 and lmo4
WO2019173394A1 (en) 2018-03-05 2019-09-12 Wylder Nation Foundation Compositions and methods for activating signaling through the cb1 cannabinoid receptor for treating and preventing diseases and disorders characterized by abnormal cellular accumulation of sphingolipids such as sphingomyelin
CN110652515A (zh) * 2018-06-29 2020-01-07 中国科学院深圳先进技术研究院 AMPK抑制剂Compound C在治疗肿瘤药物中的应用
CN109633472B (zh) * 2019-01-23 2020-11-24 刘平 一种锂电池单体的荷电状态估计算法
CN110004179B (zh) * 2019-04-16 2023-06-06 浙江诺迦生物科技有限公司 一种大麻素类活性物质的通用检测方法及其检测试剂盒
US20240207262A1 (en) * 2021-04-30 2024-06-27 National University Corporation Tokai National Higher Education And Research System Prophylactic and/or therapeutic agent for amyotrophic lateral sclerosis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580737A (en) 1990-06-11 1996-12-03 Nexstar Pharmaceuticals, Inc. High-affinity nucleic acid ligands that discriminate between theophylline and caffeine
US5567588A (en) 1990-06-11 1996-10-22 University Research Corporation Systematic evolution of ligands by exponential enrichment: Solution SELEX
US5707796A (en) 1990-06-11 1998-01-13 Nexstar Pharmaceuticals, Inc. Method for selecting nucleic acids on the basis of structure
US5763177A (en) 1990-06-11 1998-06-09 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
US5660985A (en) 1990-06-11 1997-08-26 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands containing modified nucleotides
US6699843B2 (en) 1995-06-07 2004-03-02 Gilead Sciences, Inc. Method for treatment of tumors using nucleic acid ligands to PDGF
US6011577A (en) 1997-06-30 2000-01-04 Polaroid Corporation Modular optical print head assembly
US20030198627A1 (en) 2001-09-01 2003-10-23 Gert-Jan Arts siRNA knockout assay method and constructs
WO2010030818A2 (en) 2008-09-10 2010-03-18 University Of Medicine And Dentistry Of New Jersey IMAGING INDIVIDUAL mRNA MOLECULES USING MULTIPLE SINGLY LABELED PROBES
WO2010079241A1 (es) * 2009-01-12 2010-07-15 Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion Uso de antagonistas y/o agonistas inversos de los receptores cb1 para la preparación de medicamentos que incrementen la excitabilidad de las motoneuronas

Also Published As

Publication number Publication date
ES2670590T3 (es) 2018-05-31
EP3279316B1 (en) 2023-09-20
EP3279316A1 (en) 2018-02-07
DK2733205T3 (en) 2018-04-23
EP2733205A1 (en) 2014-05-21
EP2733205B1 (en) 2018-01-10
HRP20180566T1 (hr) 2018-05-18
NO2733205T3 (enExample) 2018-06-09

Similar Documents

Publication Publication Date Title
EP2812245A4 (en) AUTOPILOT SYSTEM AND COMPONENTS AND METHOD THEREFOR
DK2831079T3 (da) BICYKLISKE HETEROCYKLISKE DERIVATER SOM MNK1- og MNK2-MODULATORER OG ANVENDELSER DERAF
EP3094946A4 (en) Orifice plates
EP2866872A4 (en) INTRAVASCULAR DEVICES, SYSTEMS AND METHODS
DK2931877T3 (da) Fremgangsmåder, som modulerer stamcellers immunregulerende virkning
EP3042639A4 (en) Absorbent product
EP3033552A4 (en) Methods for making optical components, optical components, and products including same
BR302013002177S1 (pt) Configuração aplicada em fusível.
EP3048930A4 (en) Gear track system
BR112015013892A2 (pt) simulador.
CL2012003213S1 (es) Automovil.
DK2861573T3 (da) Oxathiazin-derivater som antibakterielle og anticancer-stoffer
EP2909819B8 (en) Security devices
EP3083631A4 (en) Wnt pathway modulators
PL2650310T3 (pl) Przeciwciało przeciw-ADAMTS-5, jego pochodne i zastosowania
BR112014025974A2 (pt) folha em camadas.
IL243733A0 (en) Cyclopentane history, their preparation and medicines containing them
EP3062690A4 (en) Differential oct analysis system
BR302012006416S1 (pt) Configuração aplicada em traquéia para dispositivos de inalação.
BR112015010271A2 (pt) produto de comicronização, composição farmacêutica e seus usos
PT2733205T (pt) Neurónios motores superiores corticoespinhais, métodos e composições para diferenciar células estaminais neuronais por modulação da sinalização do recetor canabinoide cb1 e seus usos
HRP20190229T1 (hr) Ormar, postupak za izradu ormara
EP3011336A4 (en) Methods, systems, and composition related to neural disorders
EP3066631A4 (en) Foreign exchange trading
BR112015012675A2 (pt) módulo de segurança para tecnologia médica.